Advertisement

Replacement Therapy for Hemophilia

Replacement Therapy for Hemophilia

This effective treatment option for hemophilia utilizes infusions of clotting factors.

Hemophilia is a rare bleeding disorder where a person’s blood has ineffective or inadequate amounts of clotting factors—proteins that help the body stop bleeding. People who have hemophilia will bleed for a longer period of time or will be unable to stop bleeding when they have a cut or injury. They may also experience internal bleeding, such as bleeding in the joints.

The majority of hemophilia cases are caused by genetic mutations, which are either inherited from a person’s parents or occur spontaneously during fetal development. The exception to this is acquired hemophilia, a rare autoimmune condition where the immune system produces antibodies that attack clotting factors in the blood. Acquired hemophilia is most common in elderly persons.

There is no cure for hemophilia, but there are treatments that can reduce the complications associated with hemophilia. One of the most effective methods of treating hemophilia is replacement therapy.

Replacement therapy
The basic idea of replacement therapy is to add clotting factor to a person’s blood through an infusion with a clotting factor concentrate. There are two main types of clotting factor concentrates: recombinant factor concentrates and plasma-derived factor concentrates.

Plasma-derived factor concentrates are made from donated blood plasma, and in earlier decades were the only option for this type of replacement therapy. While these products undergo extensive screenings and procedures to prevent the spread of viruses and blood-borne diseases, the possibility of being exposed to a disease from a blood product still exists, which makes them a less attractive option for many patients and healthcare providers. Plasma-derived products have been used less frequently since recombinant products have become available. Recombinant factor concentrates are made in a lab using genetic engineering techniques and are considered the better option.

Prophylaxis
Replacement therapy can be used as a preventative measure, an approach called prophylaxis. It can also be used to treat an episode of bleeding that is in progress, which is known as on-demand therapy.

Prophylaxis is a very effective approach to managing hemophilia and reducing the risk of the complications associated with the disorder, including the risk of joint damage caused by bleeding in the joints and the risk of intracranial bleeding—bleeding in the brain—which is relatively rare, but can be fatal.

However, prophylaxis may not be the right treatment option for every patient. Some patients may find prophylaxis inconvenient because it requires an ongoing schedule of infusions and may require a venous catheter. It can also be expensive. Patients should discuss concerns like these with their healthcare provider. The decision to treat with prophylaxis should take into account the severity of a person’s hemophilia—how little clotting factor is present in the blood. People who have a severe deficiency may need to receive infusions on an ongoing basis. People who have moderate or mild deficiencies may only need to have infusions on an intermittent schedule.

Inhibitor development
People considering replacement therapy must also consider the possibility of inhibitor development. Inhibitor development occurs when the immune system sees the infusion of clotting factor as a foreign invader, and develops antibodies that interfere with the clotting factor. This occurs in about 20 percent of people with hemophilia A and 3 percent of people with hemophilia B. The exact cause of inhibitor development is not known, but is more common in people with African or Hispanic ethnicity, people with certain gene mutations, those who have a family history of inhibitor development and those who were initially treated with high doses of clotting factor concentrates. Inhibitor development makes treatment more complicated, and those who develop inhibitors will need additional treatments.

What Are the Different Types of Hemophilia?
What Are the Different Types of Hemophilia?
Hemophilia is a rare bleeding disorder where blood lacks adequate amounts of clotting factor—proteins in the blood that help the body stop bleeding wh...
Read More
Does hemophilia run in families?
Honor Society of Nursing (STTI)Honor Society of Nursing (STTI)
Hemophilia C is a hereditary disease, so it does run in families. Hemophilia C most commonly affects...
More Answers
What lifestyle changes should I make if I have hemophilia?
Sigma NursingSigma Nursing
If you have hemophilia, you can lead a fulfilling, long life if you manage your condition properly. ...
More Answers
What is hemophilia?
Jumo HealthJumo Health
Hemophilia is a problem that starts in the blood and causes people to bleed longer than normal. The ...
More Answers